Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer

Running, not enrolling

Conditions studied: Prostate Carcinoma

In brief

This study is being done to determine whether levels of prostate cancer derived extracellular vesicles from blood and urine specimens correlate with response to primary local treatment (surgery) in prostate cancer.

Key facts

Study ID

NCT06326216

Run by

Mayo Clinic

People needed

98

Starts

2020-06-10

Expected to finish

2026-12-01

Last updated by the study team

2026-04-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• PROSTATE CANCER PATIENTS:
• Age 18+
• Able to give informed consent
• Patients with prostate cancer
• Patients treated with primary prostatectomy
• The focus will be on high-risk patients with at least one of either criterion:
• PSA >= 20 ng/ml
• AND/OR Gleason >= 8
• AND/OR clinical stage >= T3
• FEMALE CONTROL PATIENTS:
• Age 18+
• Able to give informed consent

You may not qualify if…

• PROSTATE CANCER PATIENTS:
• Unable or unwilling to provide informed consent
• Metastatic prostate cancer - defined evidence of metastatic disease on pre-procedural testing
• FEMALE CONTROL PATIENTS:
• Unable or unwilling to provide informed consent

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.